Specimen Banking From Patients With Lung Cancer
ConditionLung Neoplasms
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorUniversity of Colorado, Denver
About this trial
The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to detect lung cancer earlier, develop better therapies and explore screening and prevention strategies.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Subjects who are undergoing further testing for the diagnosis or treatment of lung cancer.
Oral and written informed consent
Disqualifiers
None
Trial population
Subjects who are undergoing further testing for the diagnosis or treatment of lung cancer.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
2,000 Participants
are grouped into 1 trial groupGroup A: Diagnosis/treatment of lung cancer
Trial outcomes
Primary outcomes
1
Development of a comprehensive specimen banking program from patients with lung cancer for future translational research.
No statistical analysis will be applied to the overall collection of samples. Rather, each project that utilized tissue bank resources will require an appropriate statistical plan to be submitted along with the initial tissue request.
Time frame
6 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Colorado, Denver
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov